Entero Healthcare Solutions (NSE:ENTERO) ROCE %: 14.96% (As of Mar. 2026)


NSE:ENTERO Entero Healthcare Solutions Ltd NSE:ENTERO
43 GF Score
Price ₹1,200.10
! 2 Warning Signs
View Full Analysis

What is Entero Healthcare Solutions ROCE %?

Entero Healthcare Solutions NSE:ENTERO +1.67% 43 ROCE % is 14.96% as of Mar. 2026. GuruFocus rates NSE:ENTERO with a GF Score™ of 43/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Entero Healthcare Solutions's annualized ROCE % for the quarter that ended in Mar. 2026 was 14.96%.

Entero Healthcare Solutions  (NSE:ENTERO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Entero Healthcare Solutions ROCE % Related Terms

Entero Healthcare Solutions ROCE % Historical Data

* Premium members only.

The historical data trend for Entero Healthcare Solutions's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions ROCE % Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 1.04 6.04 7.91 10.02 12.08

Entero Healthcare Solutions Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.27 10.13 11.98 11.43 14.96
NSE:ENTERO
43GF Score
Entero Healthcare Solutions Ltd NSE:ENTERO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Entero Healthcare Solutions ROCE % Calculation

Entero Healthcare Solutions's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=2337.21/( ( (27025.15 - 8450.17) + (36002.63 - 15875.7) )/ 2 )
=2337.21/( (18574.98+20126.93)/ 2 )
=2337.21/19350.955
=12.08 %

Entero Healthcare Solutions's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=3010.32/( ( (0 - 0) + (36002.63 - 15875.7) )/ 1 )
=3010.32/( ( 0 + 20126.93 )/ 1 )
=3010.32/20126.93
=14.96 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 14.96% mean?
Entero Healthcare Solutions (NSE:ENTERO) has a ROCE % of 14.96% as of Mar. 2026.
Is Entero Healthcare Solutions' ROCE % too high?
Entero Healthcare Solutions' current ROCE % is 14.96%. The Medical Distribution industry median ROCE % is 9.09. Entero Healthcare Solutions' value of 14.96% is 64.6% above this industry median. Overall, Entero Healthcare Solutions has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' ROCE % compare to MCK and CAH?
Entero Healthcare Solutions' ROCE % of 14.96% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.09. Entero Healthcare Solutions' value of 14.96% is 64.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.09, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entero Healthcare Solutions's current ROCE % of 14.96% is 64.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entero Healthcare Solutions's current ROCE % is 14.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Entero Healthcare Solutions (NSE:ENTERO) has a current ROCE % of 14.96%. The current ROCE % is 14.96% and 64.6% above the Medical Distribution industry median of 9.09. Entero Healthcare Solutions' overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current ROCE % is 14.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entero Healthcare Solutions Business Description

Other Exchanges 544122:India
Address Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
43GF Score

Get the complete analysis for NSE:ENTERO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,200.10
Price